Appointment booking for Dr. Shanti Nilakantan, MD is currently not available.Dr. Shanti Nilakantan, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Shanti Nilakantan, MD (she/her) is an Endocrinologist, Internist in Long beach, CA with over 19 years of experience. What is your opinion of Dr. Shanti Nilakantan, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Shanti Nilakantan, MD has received over $1,545 which includes payments from the following companies:
$374.91 from Merck Sharp & Dohme Corporation
$193.33 from Pfizer Inc.
$147.45 from Novo Nordisk Inc
$127.96 from Janssen Pharmaceuticals, Inc
$112.35 from sanofi-aventis U.S. LLC
$111.05 from GlaxoSmithKline, LLC.
$104.60 from Takeda Pharmaceuticals America, Inc.
$93.15 from Astellas Pharma US Inc
$60.44 from LILLY USA, LLC
$49.85 from Gilead Sciences Inc
$47.77 from Boehringer Ingelheim Pharmaceuticals, Inc.
$33.41 from Daiichi Sankyo Inc.
$22.46 from Takeda Pharmaceuticals U.S.A., Inc.
$20.77 from Arbor Pharmaceuticals, Inc.
$18.41 from AstraZeneca Pharmaceuticals LP
$15.24 from FOREST PHARMACEUTICALS, INC.
$12.00 from Shionogi Inc
Payments received by Dr. Shanti Nilakantan, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!